Literature DB >> 2807579

Monoclonal antibodies against birch pollen allergens: characterization by immunoblotting and use for single-step affinity purification of the major allergen Bet v I.

E Jarolim1, M Tejkl, M Rohac, G Schlerka, O Scheiner, D Kraft, M Breitenbach, H Rumpold.   

Abstract

Two monoclonal antibodies against birch pollen proteins were produced by immunizing BALB/c mice with birch pollen extract. In immunoblotting experiments, antibody BIP 1 reacted with a 17-kilodalton (kD) protein considered to represent the major birch pollen allergen Bet v I. A second monoclonal antibody, BIP 3, reacted with 3 different birch pollen proteins of molecular weights 32, 36 and 68 kD of which the 36- and 68-kD proteins corresponded to minor allergens of birch pollen. Two-dimensional electrophoresis/immunoblotting experiments revealed that BIP 1 reacted with all Bet v I isoallergens, also identified by human IgE antibodies. Using BIP 1 coupled to Sepharose 4B as reverse immunosorbent, Bet v I was obtained in a single-step procedure and characterized as single band by SDS-PAGE.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2807579     DOI: 10.1159/000235000

Source DB:  PubMed          Journal:  Int Arch Allergy Appl Immunol        ISSN: 0020-5915


  11 in total

1.  Molecular characterization of the S-layer gene, sbpA, of Bacillus sphaericus CCM 2177 and production of a functional S-layer fusion protein with the ability to recrystallize in a defined orientation while presenting the fused allergen.

Authors:  Nicola Ilk; Christine Völlenkle; Eva M Egelseer; Andreas Breitwieser; Uwe B Sleytr; Margit Sára
Journal:  Appl Environ Microbiol       Date:  2002-07       Impact factor: 4.792

2.  Affinity-based separations and purifications. Patents and literature.

Authors:  J S Dordick
Journal:  Appl Biochem Biotechnol       Date:  1991-01       Impact factor: 2.926

3.  Protection against invasive amebiasis by a single monoclonal antibody directed against a lipophosphoglycan antigen localized on the surface of Entamoeba histolytica.

Authors:  A Marinets; T Zhang; N Guillén; P Gounon; B Bohle; U Vollmann; O Scheiner; G Wiedermann; S L Stanley; M Duchêne
Journal:  J Exp Med       Date:  1997-11-03       Impact factor: 14.307

4.  Construction of a recombinant allergen-producing probiotic bacterial strain: Introduction of a new line for a live oral vaccine against Chenopodium album pollen allergy.

Authors:  Leila Roozbeh Nasiraie; Farideh Tabatabaie; Mojtaba Sankian; Fakhri Shahidi; Abdolreza Varasteh
Journal:  Rep Biochem Mol Biol       Date:  2013-10

5.  Influence of the route of sensitization on local and systemic immune responses in a murine model of type I allergy.

Authors:  A Repa; C Wild; K Hufnagl; B Winkler; B Bohle; A Pollak; U Wiedermann
Journal:  Clin Exp Immunol       Date:  2004-07       Impact factor: 4.330

6.  Molecular characterization of recombinant T1, a non-allergenic periwinkle (Catharanthus roseus) protein, with sequence similarity to the Bet v 1 plant allergen family.

Authors:  Sylvia Laffer; Said Hamdi; Christian Lupinek; Wolfgang R Sperr; Peter Valent; Petra Verdino; Walter Keller; Monika Grote; Karin Hoffmann-Sommergruber; Otto Scheiner; Dietrich Kraft; Marc Rideau; Rudolf Valenta
Journal:  Biochem J       Date:  2003-07-01       Impact factor: 3.857

7.  Dissection of immunoglobulin E and T lymphocyte reactivity of isoforms of the major birch pollen allergen Bet v 1: potential use of hypoallergenic isoforms for immunotherapy.

Authors:  F Ferreira; K Hirtenlehner; A Jilek; J Godnik-Cvar; H Breiteneder; R Grimm; K Hoffmann-Sommergruber; O Scheiner; D Kraft; M Breitenbach; H J Rheinberger; C Ebner
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

Review 8.  Current overview of allergens of plant pathogenesis related protein families.

Authors:  Mau Sinha; Rashmi Prabha Singh; Gajraj Singh Kushwaha; Naseer Iqbal; Avinash Singh; Sanket Kaushik; Punit Kaur; Sujata Sharma; Tej P Singh
Journal:  ScientificWorldJournal       Date:  2014-02-16

9.  Stabilization of the dimeric birch pollen allergen Bet v 1 impacts its immunological properties.

Authors:  Stefan Kofler; Chloé Ackaert; Martin Samonig; Claudia Asam; Peter Briza; Jutta Horejs-Hoeck; Chiara Cabrele; Fatima Ferreira; Albert Duschl; Christian Huber; Hans Brandstetter
Journal:  J Biol Chem       Date:  2013-11-19       Impact factor: 5.157

10.  Mimotopes for Api g 5, a Relevant Cross-reactive Allergen, in the Celery-Mugwort-Birch-Spice Syndrome.

Authors:  Anna Lukschal; Julia Wallmann; Merima Bublin; Gerlinde Hofstetter; Nadine Mothes-Luksch; Heimo Breiteneder; Isabella Pali-Schöll; Erika Jensen-Jarolim
Journal:  Allergy Asthma Immunol Res       Date:  2015-10-16       Impact factor: 5.764

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.